← Back to headlines
First Clinical Trial for Corneal Disease Treatment Using iPS Cells Begins in Japan
The first clinical trial to treat corneal disease using iPS cell-derived corneal tissue has commenced at Osaka University Hospital in Japan, aiming to restore vision for patients. The company conducting the trial plans to seek national approval in two years.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
